Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Journal of hematology & oncology"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Subbiah%2C+Vivek%22&type=Person&filter%5B%5D=journalStr%3A%22Journal+of+hematology+%26+oncology%22
/vufind/Search/Results?lookfor=%22Subbiah%2C+Vivek%22&type=Person&filter%5B%5D=journalStr%3A%22Journal+of+hematology+%26+oncology%22
Search /vufind/Search2/Results?lookfor=%22Subbiah%2C+Vivek%22&type=Person&filter%5B%5D=journalStr%3A%22Journal+of+hematology+%26+oncology%22
PubPharm (11)
1
Drugging KRAS : current perspectives and state-of-art review
enthalten in:
Journal of hematology & oncology
| 2022
von
Parikh, K.
|
Banna, G.
|
Liu, S.
| +4
Wird geladen...
2
Drugging KRAS: current perspectives and state-of-art review
enthalten in:
Journal of hematology & oncology
| 2022
von
Parikh, K.
|
Banna, G.
|
Liu, S.
| +4
Wird geladen...
3
Drugging KRAS: current perspectives and state-of-art review
enthalten in:
Journal of hematology & oncology
| 2022
von
Parikh, K.
|
Banna, G.
|
Liu, S.
| +4
Wird geladen...
4
Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations : case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response
enthalten in:
Journal of hematology & oncology
| 2022
von
Persha, H.
|
Kato, S.
|
De, P.
| +4
Wird geladen...
5
Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response
enthalten in:
Journal of hematology & oncology
| 2022
von
Persha, H.
|
Kato, S.
|
De, P.
| +4
Wird geladen...
6
STUMP un"stumped" : anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion
enthalten in:
Journal of hematology & oncology
| 2015
von
Subbiah, V.
|
McMahon, C.
|
Patel, S.
| +17
Wird geladen...
7
STUMP un“stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion
enthalten in:
Journal of hematology & oncology
| 2015
von
Subbiah, V.
|
McMahon, C.
|
Patel, S.
| +17
Wird geladen...
8
Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial
enthalten in:
Journal of hematology & oncology
| 2014
von
Subbiah, V.
|
Meric-Bernstam, F.
|
Mills, G.
| +5
Wird geladen...
9
Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial
enthalten in:
Journal of hematology & oncology
| 2014
von
Subbiah, V.
|
Meric-Bernstam, F.
|
Mills, G.
| +5
Wird geladen...
10
Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein
enthalten in:
Journal of hematology & oncology
| 2014
von
Subbiah, V.
|
Westin, S.
|
Wang, K.
| +7
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Journal of hematology & oncology
Medienart
11
Aufsätze
11
E-Artikel
11
E-Ressourcen
Zeitschriftentitel
Journal of hematology & oncology
Thema
5
Targeted therapy
4
Journal Article
3
Case Reports
3
Research Support, N.I.H., Extramural
3
Research Support, Non-U.S. Gov't
2
Antineoplastic Agents
2
Bevacizumab
2
EC 2.7.10.1
2
Genomic
2
Next generation sequencing
2
Osteosarcoma
2
Precision
2
Protein Kinase Inhibitors
2
Sarcoma
2
Sorafenib
2
Sunitinib
1
25X51I8RD4
1
2S9ZZM9Q9V
1
62031-54-3
1
624KN6GM2T
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5
2020-
6
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
11
Englisch
Haven't found what you're looking for?
Wird geladen...